Lung Cancer Surgery Market

Lung Cancer Surgery Market by Product, by Application, by End user & Region | Forecast 2022 to 2029

Market Insights on Lung Cancer Surgery covering sales outlook, demand forecast and up-to-date key trends

Request Sample

Lung Cancer Surgery Market Snapshot (2022 to 2029)

The global Lung Cancer Surgery Market was valued at US$ 1.23 Billion in 2021 and is expected to reach US$ 1.98 Billion by 2029, finds Future Market Insights (FMI) in a recent market survey.

Data Points	Market Insights
Market Value 2021	USD 1.23 Billion
Market Value 2022	USD 1.31 Billion
Market Value 2029	USD 1.98 Billion
CAGR 2022 to 2029	6.1%
Share of Top 5 Countries	61.5%
Key Players	The key players in the lung cancer surgery market are Asap Endoscopic Products, Ethicon Inc. (J & J), Medtronic Plc., Germed USA Inc., Teleflex Incorporated, B. Braun Melsungen AG, Karl Storz, Richard Wolf, Olympus Medical Systems Corp, Intuitive Surgical Inc., Ambu A/S, PENTAX Medical Company and FUJIFILM Holdings Corporation

Lung cancer refers to the growth of abnormal cells in the lung tissue. Non-small cell lung cancer (NSCLC) and small cell lung cancer (SCLC) are the two major types of lung cancer. Treatment options for lung cancer usually include various types of therapies such as chemotherapy, radiation therapy, immunotherapy, targeted drug therapy and surgery.

Attempts to cure the disease with surgery involve the removal of the tumour, the surrounding lung tissue, and lymph nodes in the tumour area. Surgery is considered the treatment of choice for localized cancer, including carcinoid tumours.

The rising level of air pollution in developing economies and the increasing research and development activities on cancer treatment are some of the major trends bolstering the market outlook. The National Cancer Institute, for example, has been significantly offering funds to promote new cancer treatments and improve patient care, which in turn, could boost the acceptance of lung cancer removal surgery globally.

The lung cancer surgery market holds nearly 10% of the US$ 12 Billion cancer surgery market in 2021. Additionally, substantial investment in research laboratories, the surge in air pollution levels, and increasing smoking habits coupled with favourable reimbursement policies, specifically in developed countries will strengthen the growth of the lung cancer surgery market.

Don't pay for what you don't need

Customize your report by selecting specific countries or regions and save 30%!

How The Market Progressed Till June 2022?

Particulars	Details
H1, 2021	6.15%
H1, 2022 Projected	6.12%
H1, 2022 Outlook	6.02%
BPS Change - H1, 2022 (O) – H1, 2022 (P)	(-) 10 ↓
BPS Change – H1, 2022 (O) – H1, 2021	(-) 12 ↓

The growth rates and development prospects of the global lung cancer surgery market are reviewed by FMI. The market is influenced by the development of robotic surgery techniques as well as innovative systemic treatments as a result of the impact of macro and industrial determinants. Growing lobectomy adoption among patients of all ages, as well as rising surgical treatment affordability, are all vital market prospects.

The market growth rate of lung cancer surgery will witness a drop by 12 Basis Point Share (BPS) in H1-2022, according to FMI. However the difference in BPS value between H1- 2022 Outlook and H1-2022 Projected showed a decline in BPS value by 10 BPS. Owing to the morbid effects of detectable lung cancer, the importance of surgical resection procedures was well established with the advent of the COVID-19 pandemic.

The reduced volumes of surgical procedures globally, imposed a restrictive impact on the overall lung cancer surgery market, with relevance to concerns regarding the proliferation of infectious agents.

Two positives for the industry are the rise of minimally invasive techniques, sublobar resection and LND indication for early-stage NSCLC, and targeted therapy and immunotherapy combination with lung cancer surgery for advanced-stage and metastatic lung malignancies. Ongoing research and development in this field show promising growth within this market in the future.

Lung Cancer Surgery Market

2014 to 2021 Market Demand Outlook for Lung Cancer Surgery compared to 2022 to 2029 Forecast

Rising air pollution and the people getting affected by it are one of the prime factors responsible for the growth of the lung cancer surgery market. As per the lung cancer research foundation, lung cancer is the main reason for cancer death across the world.

According to the American Cancer Society, it is estimated that in 2022, around 236,740 adults in the USA will be diagnosed with lung cancer while there will be 130,180 cases of deaths due to lung cancer in the same year. Smoking is the prominent risk factor for lung cancer and is responsible for 80% of lung cancer deaths. Non-smokers account for 20% of lung cancer deaths.

Exposure to radon gas is another risk factor for lung cancer. This indicates the burden of lung cancer in the region and this is resulting in the growth of the lung cancer surgery market as there is a high demand for cancer treatment in the USA

The demand for lung cancer surgery grew at a CAGR of 5.5% between 2014 and 2021 globally. The rise in cases of lung cancer expects to raise the demand for lung cancer surgery.

Growing incidences of lung cancer are expected to favor the demand for lung cancer surgery devices, owing to the large patient pool and need for effective treatment. Lung cancer incidences are increasing rapidly with the increase in the high smoking rates, environmental pollution, and workplace exposures in milling, construction, and automobile repairs.

Similarly, cigarette smoking is also one of the most common and known factors for developing lung cancer. Men who smoke often have 23 times more chances to develop lung cancer compared to non-smokers. Non-smokers have 20 to 30% chances of developing lung cancer due to exposure to secondhand smoke at work and at home.

The lung cancer surgery market is expected to grow in the future, as the emergence of the latest technologies in the medical sector and the introduction of technologically advanced surgical energy instruments are magnifying the demand for this market. Advanced endoscopic devices and surgical instruments have increased the device versatility, thus easing their use of it in complex cases, leading to an increase in the number of lung resection procedures. Technology transformation has led to a positive impact on the global lung cancer surgery market growth.

Considering this, FMI expects global lung cancer surgery to grow at a CAGR of 6.1% through 2029.

Sabyasachi Ghosh

Principal Consultant

Talk to Analyst

Find your sweet spots for generating winning opportunities in this market.

Which Factors Are Restraining the Demand for Lung Cancer Surgery?

Lung cancer surgeries such as lobectomy, wedge resection, and other procedures are very high-cost surgeries. Affordability of the endoscopy and video-assisted lung surgery procedures is a major problem for a huge chunk of the population in the region. This is due to the absence of health insurance and limited government support policies that cover video-assisted surgeries in developing countries such as South Africa, India, and China.

The absence of social health insurance together with the exclusionary provision of private health insurance schemes is another major factor limiting the lung cancer surgery market growth. Furthermore, post-surgery infections and risks associated with lung surgery are also expected to hamper the growth of the lung cancer surgery market.

Lung resection procedures are often associated with various post-surgery complications and infections in some patients. Air leak is the most common complication after the lung resection procedure. Around 15% to 20% of patients reported air leaks after lung resection surgery. Some of the other complications associated with lung resection surgery include bacterial pneumonia, acute respiratory failure, pulmonary embolism, postoperative haemorrhage, comorbid cardiovascular conditions, and other conditions. All these factors might result in restraining the demand for these procedures during the forecast period.

Country-wise Insights

What Makes the USA a Large Market for Lung Cancer Surgery?

In 2021, the USA is expected to account for about 93.9% of the North American lung cancer surgery market due to ease in FDA clearance encouraging lung cancer surgery device manufacturers in the region. For endoscope medical devices, the FDA 510(k) premarket approval process is followed. The Food and Drug Administration (FDA) has provided a list of class II (special control) devices that were subjected to certain limitations and which are now exempted from premarket notification requirements as per the Food and Drug Administration Modernization Act of 1997 (known as Modernization Act).

As per the Modernization Act and the related exemptions, device manufacturers and developers are relieved from the need to submit premarket submissions. Thus, enabling FDA to redirect resources to more significant public health issues. This helps minimize the time taken for regulatory approvals. Thus, reducing costs significantly and propelling the growth of the thoracoscope, and bronchoscope markets as well as boosting the growth of the lung cancer surgery devices market in the USA

Why is Germany Considered a Lucrative Market for Lung Cancer Surgery?

Germany is expected to account for 24.2% of the European market by 2021. The country dominates the European market owing to the high prevalence of lung cancer in Germany.

As per World Health Organization and Globocan, a total of 64,804 individuals were identified to have lung cancer in Germany which is nearly 10% of the total 628,519 cancer cases in 2020. Lung cancer was ranked 3rd on basis of its incidence rates while it was considered the top reason behind the deaths caused by cancer.

What are the Factors Fueling the Demand for Lung Cancer Surgery in China?

The market for lung cancer surgery in China is projected to grow at 7.8% CAGR in the East Asia region throughout the forecast period. The high prevalence of lung cancer among the older population led to increased demand for lung cancer surgeries in China.

The rapid rise in China’s adult population suffering from lung cancer is anticipated to boost the growth of the country’s lung cancer surgery market. This is because the maximum number of people diagnosed with lung cancer are 65 years and older. A small number of people aged below 45 are diagnosed with lung cancer. According to the WHO, by 2040, the elder population is expected to grow by 28% in China.

As per Globocan, Lung cancer was ranked 1st when considering the number of new cases (incidence rate) and highest no of deaths (mortality rate) due to different types of cancer. Around 815,563 new cases of lung cancer were identified in 2020 in China, whereas 714,699 cases of deaths were reported due to the same.

How will the Lung Cancer Surgery Market expand across India?

Demand for lung cancer surgery in India is expected to rise at an impressive 6.8% CAGR over the forecast period. Asian countries have the highest population suffering from Chronic obstructive pulmonary disease (COPD), thus the risk of developing lung cancer increases significantly in the region. The number of COPD cases in India was a shocking 55.3 million in 2016.

The threat of lung cancer in patients with COPD is two- to fivefold more compared with smokers without COPD. COPD prevalence is rising at a very high rate which is expected to increase the risk of lung cancer and favor the growth of the lung cancer surgery market over the forecast period in India. Moreover, as per the report published by WHO, levels of ultra-fine particles of less than 2.5 microns are the maximum in India, which led India to become the 16th most polluted city in the world, among the 30 most polluted cities. Thus, a rise in air pollution is primarily driving the lung cancer rate, and hence the Indian market is expected to be impacted.

Category-wise Insights

Surgical Energy Instruments anticipated continuing Gaining Traction

Based on the product type, the surgical energy instruments segment holds the maximum share of 42.5% in 2021, expanding at 6.6% CAGR during the forecast period. Advanced surgical instruments have increased the device adaptability and ease of use in complex surgical procedures, which drives lung cancer surgical procedures. Furthermore, Technology transformation has supplemented the growth of the surgical energy instruments segment.

Why does lobectomy contribute the highest market share by application?

In terms of Application, the lobectomy segment accounted for 68.0% of the total market share in 2021. Growing acceptance of VATS lobectomy is expected to favor the demand for endoscopic surgery equipment and advanced energy equipment and drive the growth of the lobectomy segment.

Which End User will be Most Preferred?

By End Users, Hospitals hold over 78.8% of the market in 2021 and this trend is expected to continue during the forecast period as well.

Competitive Landscape

Market players lay greater emphasis on collaboration and partnership activities with local and regional players to expand sales and after-sales services for lung cancer surgery devices.

Through partnerships and acquisitions with regional players and third-party service vendors, manufacturers expand their presence and product availability on a global level which is anticipated to fuel the growth of the lung cancer surgery devices market. For instance:

In June 2021, Intuitive launched the robotic-assisted surgical stapler SureForm.
In December 2020, Medtronic Private Limited launched the first 3-row Circular Stapler with varied height staples - EEA Circular Stapler with Tri-Staple Technology in India.
In April 2019, Johnson & Johnson completed the acquisition of Auris Health Inc. a robotic platform technology manufacturer.
In March 2019, Titan Medical collaborated with Teleflex Inc. for the development of robotic ligation technology.

Scope of the Report

Attribute	Details
Forecast Period	2022 to 2029
Historical Data Available for	2014 to 2021
Market Analysis	USD Million for Value
Key Regions Covered	North America, Latin America, Europe, South Asia, East Asia, Oceania, and Middle East & Africa
Key Countries Covered	USA, Canada, Brazil, Mexico, Poland, Russia, France, United Kingdom, Germany, Spain, Italy, Benelux, Nordic, China, India, Australia and New Zealand, ASEAN, GCC Countries, Turkey, North Africa, and South Africa
Key Segments Covered	Product Type, Application, End-User, and Region
Key Companies Profiled	Asap Endoscopic Products Ethicon Inc. (J & J) Medtronic Plc. Germed USA Inc. Teleflex Incorporated B. Braun Melsungen AG Karl Storz Richard Wolf Olympus Medical Systems Corp Intuitive Surgical Inc. Ambu A/S PENTAX Medical Company FUJIFILM Holdings Corporation
Report Coverage	Market Forecast, Competition Intelligence, Drivers, Restraints, Opportunities and Threats Analysis, Market Dynamics and Challenges, Strategic Growth Initiatives
Customization & Pricing	Available upon Request

Lung Cancer Surgery Market by Category

By Product:

Thoracoscopes
Mediastinoscopes
Bronchoscopes
Robotic-Assisted Thoracic Surgery Systems
Surgical Staplers
Surgical Energy Instruments
- Advanced Energy Instruments
  - Advanced Bipolar Instruments
  - Ultrasonic Instruments
- Basic Energy Instruments
  - Bipolar Instruments
  - Monopolar Instruments

By Application:

Lobectomy
Segmentectomy
Wedge Resection
Pneumonectomy

By End-User:

Hospitals
Ambulatory Surgical Centers

By Region:

North America
Latin America
Europe
East Asia
South Asia
Oceania
Middle East and Africa (MEA)

Frequently Asked Questions

How much is the lung cancer surgery market currently worth?

The global lung cancer surgery market is worth US$ 1.23 Billion in 2021 and is set to expand 1.5X over the next seven years.

What is the sales forecast for lung cancer surgery through 2029?

The lung cancer surgery market is expected to reach US$ 1.98 Billion by the end of 2029, with sales revenue expected to grow at a 6.1% CAGR.

What are the factors driving the demand outlook of global lung cancer surgery?

The global market for lung cancer surgery is projected to reflect high demand in the forecast period with a CAGR of 6.1% owing to the rising prevalence of COPD and increased risk of lung cancer.

Which is the most lucrative market for lung cancer surgery?

North America currently holds the largest market share in the lung cancer surgery market globally. North America currently holds 36.5% of the global market share in the lung cancer surgery market with the USA being the leading contributor with a market value of over US$ 421.5 Million in 2021.

How likely is the Lung Cancer Surgery Market to grow in India?

The lung cancer surgery market in India is likely to grow at a CAGR of 6.8% during the forecast period, with a market share of around 48.8% in 2021 of the South Asia market for lung cancer surgery. The rising prevalence of COPD and lung cancer in India, and growing awareness among the population are responsible for the growth of the lung cancer surgery market in India.

What are key trends driving sales of lung cancer surgery?

The growing focus on the introduction of new robotic surgery systems and the increasing launch of new endovascular technology for tissue-specific vessel sealing and stapling techniques are the major key trends in the lung cancer surgery market.

What are the key market statistics in Japan?

Japan’s market in lung cancer surgery is offering lucrative growth opportunities and is expected to exhibit healthy growth of 6.3% CAGR during the forecast period.

What are the top 5 countries driving demand for lung cancer surgery?

The USA, China, Germany, Japan, and the United Kingdom are the top 5 countries that are driving the demand for lung cancer surgery.

Which are the leading companies in the lung cancer surgery market?

Leading companies in lung cancer surgery are Asap Endoscopic Products, Ethicon Inc. (J & J), Medtronic Plc., Germed USA Inc., Teleflex Incorporated, B. Braun Melsungen AG, Karl Storz, Richard Wolf, Olympus Medical Systems Corp, Intuitive Surgical Inc., Ambu A/S, PENTAX Medical Company, and FUJIFILM Holdings Corporation.

Table of Content

1. Executive Summary | Lung Cancer Surgery Market

1.1. Global Market Outlook

1.2. Demand Side Trends

1.3. Supply Side Trends

1.4. Analysis and Recommendations

2. Market Overview

2.1. Market Coverage / Taxonomy

2.2. Market Definition / Scope / Limitations

3. Key Market Trends

3.1. Key Trends Impacting the Market

3.2. Product Innovation / Development Trends

4. Key Success Factors

4.1. Key Product USP Analysis

4.2. Regulatory Scenario

4.3. Reimbursement Scenario

4.4. Value Chain

4.5. Disease Epidemiology by Region

5. Global Market Demand (in Value or Size in US$ Million) Analysis 2014 to 2021and Forecast, 2022 to 2029

5.1. Historical Market Value (US$ Million) Analysis, 2014 to 2021

5.2. Current and Future Market Value (US$ Million) Projections, 2022 to 2029

5.2.1. Y-o-Y Growth Trend Analysis

5.2.2. Absolute $ Opportunity Analysis

6. Market Background

6.1. Macro-Economic Factors

6.1.1. Global GDP Growth Outlook

6.1.2. Global Healthcare Market Outlook

6.2. Forecast Factors - Relevance & Impact

6.3. Market Dynamics

6.3.1. Drivers

6.3.2. Restraints

6.3.3. Opportunity Analysis

7. Global Market Analysis 2014 to 2021 and Forecast 2022 to 2029, by Product Type

7.1. Introduction / Key Findings

7.2. Historical Market Size (US$ Million) Analysis By Product Type, 2014 to 2021

7.3. Current and Future Market Size (US$ Million) Analysis and Forecast By Product Type, 2022 to 2029

7.3.1. Thoracoscopes

7.3.2. Mediastinoscopes

7.3.3. Bronchoscopes

7.3.4. Robotic-Assisted Thoracic Surgery Systems

7.3.5. Surgical Staplers

7.3.6. Surgical Energy Instruments

7.3.6.1. Advanced Energy Instruments

7.3.6.1.1. Advanced Bipolar Instruments

7.3.6.1.2. Ultrasonic Instruments

7.3.6.2. Basic Energy Instruments

7.3.6.2.1. Bipolar Instruments

7.3.6.2.2. Monopolar Instruments

7.4. Market Attractiveness Analysis By Product Type

8. Global Market Analysis 2014 to 2021 and Forecast 2022 to 2029, by Application

8.1. Introduction / Key Findings

8.2. Historical Market Size (US$ Million) Analysis By Application, 2014 to 2021

8.3. Current and Future Market Size (US$ Million) Analysis and Forecast By Application, 2022 to 2029

8.3.1. Lobectomy

8.3.2. Segmentectomy

8.3.3. Wedge Resection

8.3.4. Pneumonectomy

8.4. Market Attractiveness Analysis By Application

9. Global Market Analysis 2014 to 2021 and Forecast 2022 to 2029, by End User

9.1. Introduction / Key Findings

9.2. Historical Market Size (US$ Million) Analysis By End User, 2014 to 2021

9.3. Current and Future Market Size (US$ Million) Analysis and Forecast By End User, 2022 to 2029

9.3.1. Hospitals

9.3.2. Ambulatory Surgical Centers

9.4. Market Attractiveness Analysis By End User

10. Market Analysis 2014 to 2021 and Forecast 2022 to 2029, By Region

10.1. Introduction

10.2. Historical Market Size (US$ Million) Analysis By End User, 2014 to 2021

10.3. Current Market Size (US$ Million) Analysis and Forecast By Region, 2022 to 2029

10.3.1. North America

10.3.2. Latin America

10.3.3. Europe

10.3.4. Middle East and Africa (MEA)

10.3.5. East Asia

10.3.6. South Asia

10.3.7. Oceania

10.4. Market Attractiveness Analysis By Region

11. North America Market Analysis 2014 to 2021 and Forecast 2022 to 2029

11.1. Introduction

11.2. Historical Market Size (US$ Million) Trend Analysis By Market Taxonomy, 2014 to 2021

11.3. Market Size (US$ Million) Forecast By Market Taxonomy, 2022 to 2029

11.3.1. By Country

11.3.1.1. USA

11.3.1.2. Canada

11.3.2. By Product Type

11.3.3. By Application

11.3.4. By End User

11.4. Market Attractiveness Analysis

11.4.1. By Country

11.4.2. By Product Type

11.4.3. By Application

11.4.4. By End User

12. Latin America Market Analysis 2014 to 2021 and Forecast 2022 to 2029

12.1. Introduction

12.2. Historical Market Size (US$ Million) Trend Analysis By Market Taxonomy, 2014 to 2021

12.3. Market Size (US$ Million) Forecast By Market Taxonomy, 2022 to 2029

12.3.1. By Country

12.3.1.1. Brazil

12.3.1.2. Mexico

12.3.1.3. Rest of Latin America

12.3.2. By Product Type

12.3.3. By Application

12.3.4. By End User

12.4. Market Attractiveness Analysis

12.4.1. By Country

12.4.2. By Product Type

12.4.3. By Application

12.4.4. By End User

13. Europe Market Analysis 2014 to 2021 and Forecast 2022 to 2029

13.1. Introduction

13.2. Historical Market Size (US$ Million) and Trend Analysis By Market Taxonomy, 2014 to 2021

13.3. Market Size (US$ Million) and By Market Taxonomy, 2022 to 2029

13.3.1. By Country

13.3.1.1. Germany

13.3.1.2. Italy

13.3.1.3. France

13.3.1.4. United Kingdom

13.3.1.5. Spain

13.3.1.6. Russia

13.3.1.7. Rest of Europe

13.3.2. By Product Type

13.3.3. By Application

13.3.4. By End User

13.4. Market Attractiveness Analysis

13.4.1. By Country

13.4.2. By Product Type

13.4.3. By Application

13.4.4. By End User

14. South Asia Market Analysis 2014 to 2021 and Forecast 2022 to 2029

14.1. Introduction

14.2. Historical Market Size (US$ Million) and Trend Analysis By Market Taxonomy, 2014 to 2021

14.3. Market Size (US$ Million) and Forecast By Market Taxonomy, 2022 to 2029

14.3.1. By Country

14.3.1.1. India

14.3.1.2. Thailand

14.3.1.3. Indonesia

14.3.1.4. Malaysia

14.3.1.5. Rest of South Asia

14.3.2. By Product Type

14.3.3. By Application

14.3.4. By End User

14.4. Market Attractiveness Analysis

14.4.1. By Country

14.4.2. By Product Type

14.4.3. By Application

14.4.4. By End User

15. East Asia Market Analysis 2014 to 2021 and Forecast 2022 to 2029

15.1. Introduction

15.2. Historical Market Size (US$ Million) and Trend Analysis By Market Taxonomy, 2014 to 2021

15.3. Market Size (US$ Million) and Forecast By Market Taxonomy, 2022 to 2029

15.3.1. By Country

15.3.1.1. China

15.3.1.2. Japan

15.3.1.3. South Korea

15.3.2. By Product Type

15.3.3. By Application

15.3.4. By End User

15.4. Market Attractiveness Analysis

15.4.1. By Country

15.4.2. By Product Type

15.4.3. By Application

15.4.4. By End User

16. Oceania Market Analysis 2014 to 2021 and Forecast 2022 to 2029

16.1. Introduction

16.2. Historical Market Size (US$ Million) and Trend Analysis By Market Taxonomy, 2014 to 2021

16.3. Market Size (US$ Million) and Forecast By Market Taxonomy, 2022 to 2029

16.3.1. By Country

16.3.1.1. Australia

16.3.1.2. New Zealand

16.3.2. By Product Type

16.3.3. By Application

16.3.4. By End User

16.4. Market Attractiveness Analysis

16.4.1. By Country

16.4.2. By Product Type

16.4.3. By Application

16.4.4. By End User

17. Middle East and Africa Market Analysis 2014 to 2021 and Forecast 2022 to 2029

17.1. Introduction

17.2. Historical Market Size (US$ Million) and Trend Analysis By Market Taxonomy, 2014 to 2021

17.3. Market Size (US$ Million) and Forecast By Market Taxonomy, 2022 to 2029

17.3.1. By Country

17.3.1.1. GCC Countries

17.3.1.2. Turkey

17.3.1.3. Northern Africa

17.3.1.4. South Africa

17.3.1.5. Rest of Middle East and Africa

17.3.2. By Product Type

17.3.3. By Application

17.3.4. By End User

17.4. Market Attractiveness Analysis

17.4.1. By Country

17.4.2. By Product Type

17.4.3. By Application

17.4.4. By End User

18. Emerging Countries Market Analysis 2014 to 2021 and Forecast 2022 to 2029

18.1. Introduction

18.1.1. Market Value Proportion Analysis, By Key Countries

18.1.2. Global Vs. Country Growth Comparison

18.2. China Market Analysis

18.2.1. Introduction

18.2.2. Market Value Proportion Analysis by Market Taxonomy

18.2.3. Market Value (US$ Million) Analysis and Forecast by Market Taxonomy

18.2.3.1. By Product Type

18.2.3.2. By Application

18.2.3.3. By End User

18.2.4. China Market - Competition Landscape

18.3. India Market Analysis

18.3.1. Introduction

18.3.2. Market Value Proportion Analysis by Market Taxonomy

18.3.3. Market Value (US$ Million) Analysis and Forecast by Market Taxonomy

18.3.3.1. By Product Type

18.3.3.2. By Application

18.3.3.3. By End User

18.3.4. India Market - Competition Landscape

18.4. Brazil Market Analysis

18.4.1. Introduction

18.4.2. Market Value Proportion Analysis by Market Taxonomy

18.4.3. Market Value (US$ Million) Analysis and Forecast by Market Taxonomy

18.4.3.1. By Product Type

18.4.3.2. By Application

18.4.3.3. By End User

18.4.4. Brazil Market - Competition Landscape

19. Market Structure Analysis

19.1. Market Analysis by Tier of Companies

19.2. Market Concentration

19.3. Market Share Analysis of Top Players

20. Competition Analysis

20.1. Competition Dashboard

20.2. Competition Deep Dive

20.2.1. Asap Endoscopic Products

20.2.1.1. Overview

20.2.1.2. Product Portfolio

20.2.1.3. Profitability by Market Segments (Product/Channel/Region)

20.2.1.4. Sales Footprint

20.2.1.5. Strategy Overview

20.2.2. Ethicon Inc. (J & J)

20.2.2.1. Overview

20.2.2.2. Product Portfolio

20.2.2.3. Profitability by Market Segments (Product/Channel/Region)

20.2.2.4. Sales Footprint

20.2.2.5. Strategy Overview

20.2.3. Medtronic Plc.

20.2.3.1. Overview

20.2.3.2. Product Portfolio

20.2.3.3. Profitability by Market Segments (Product/Channel/Region)

20.2.3.4. Sales Footprint

20.2.3.5. Strategy Overview

20.2.4. Germed USA Inc.

20.2.4.1. Overview

20.2.4.2. Product Portfolio

20.2.4.3. Profitability by Market Segments (Product/Channel/Region)

20.2.4.4. Sales Footprint

20.2.4.5. Strategy Overview

20.2.5. Teleflex Incorporated

20.2.5.1. Overview

20.2.5.2. Product Portfolio

20.2.5.3. Profitability by Market Segments (Product/Channel/Region)

20.2.5.4. Sales Footprint

20.2.5.5. Strategy Overview

20.2.6. B. Braun Melsungen AG

20.2.6.1. Overview

20.2.6.2. Product Portfolio

20.2.6.3. Profitability by Market Segments (Product/Channel/Region)

20.2.6.4. Sales Footprint

20.2.6.5. Strategy Overview

20.2.7. Karl Storz

20.2.7.1. Overview

20.2.7.2. Product Portfolio

20.2.7.3. Profitability by Market Segments (Product/Channel/Region)

20.2.7.4. Sales Footprint

20.2.7.5. Strategy Overview

20.2.8. Richard Wolf

20.2.8.1. Overview

20.2.8.2. Product Portfolio

20.2.8.3. Profitability by Market Segments (Product/Channel/Region)

20.2.8.4. Sales Footprint

20.2.8.5. Strategy Overview

20.2.9. Olympus Medical Systems Corp

20.2.9.1. Overview

20.2.9.2. Product Portfolio

20.2.9.3. Profitability by Market Segments (Product/Channel/Region)

20.2.9.4. Sales Footprint

20.2.9.5. Strategy Overview

20.2.10. Intuitive Surgical Inc.

20.2.10.1. Overview

20.2.10.2. Product Portfolio

20.2.10.3. Profitability by Market Segments (Product/Channel/Region)

20.2.10.4. Sales Footprint

20.2.10.5. Strategy Overview

20.2.11. Ambu A/S

20.2.11.1. Overview

20.2.11.2. Product Portfolio

20.2.11.3. Profitability by Market Segments (Product/Channel/Region)

20.2.11.4. Sales Footprint

20.2.11.5. Strategy Overview

20.2.12. PENTAX Medical Company

20.2.12.1. Overview

20.2.12.2. Product Portfolio

20.2.12.3. Profitability by Market Segments (Product/Channel/Region)

20.2.12.4. Sales Footprint

20.2.12.5. Strategy Overview

20.2.13. FUJIFILM Holdings Corporation

20.2.13.1. Overview

20.2.13.2. Product Portfolio

20.2.13.3. Profitability by Market Segments (Product/Channel/Region)

20.2.13.4. Sales Footprint

20.2.13.5. Strategy Overview

21. Assumptions and Acronyms Used

22. Research Methodology

List of Tables

Table 01: Global Market Analysis 2014 to 2021 and Forecast 2022 to 2029, By Product Type

Table 02: Global Market Analysis 2014 to 2021 and Forecast 2022 to 2029, By Application

Table 03: Global Market Analysis 2014 to 2021 and Forecast 2022 to 2029, By End User

Table 04: Global Market Analysis 2014 to 2021 and Forecast 2022 to 2029, By Region

Table 05: Expenditure on Health, (% of GDP), by Country, 2016 to 2020 (1/2)

Table 06: Expenditure on Health, (% of GDP), by Country, 2016 to 2020 (2/2)

Table 07: North America Market Value (US$ Million) Analysis 2014 to 2021 and Forecast 2022 to 2029, By Country

Table 08: North America Market Value (US$ Million) Analysis 2014 to 2021 and Forecast 2022 to 2029, By Product Type

Table 9: North America Market Value (US$ Million) Analysis 2014 to 2021 and Forecast 2022 to 2029, By Application

Table 10: North America Market Value (US$ Million) Analysis 2014 to 2021 and Forecast 2022 to 2029, By End User

Table 11: Latin America Market Value (US$ Million) Analysis 2014 to 2021 and Forecast 2022 to 2029, By Country

Table 12: Latin America Market Value (US$ Million) Analysis 2014 to 2021 and Forecast 2022 to 2029, By Product Type

Table 13: Latin America Market Value (US$ Million) Analysis 2014 to 2021 and Forecast 2022 to 2029, By Application

Table 14: Latin America Market Value (US$ Million) Analysis 2014 to 2021 and Forecast 2022 to 2029, By End User

Table 15: Europe Market Value (US$ Million) Analysis 2014 to 2021 and Forecast 2022 to 2029, By Country

Table 16: Europe Market Value (US$ Million) Analysis 2014 to 2021 and Forecast 2022 to 2029, By Product Type

Table 17: Europe Market Value (US$ Million) Analysis 2014 to 2021 and Forecast 2022 to 2029, By Application

Table 18: Europe Market Value (US$ Million) Analysis 2014 to 2021 and Forecast 2022 to 2029, By End User

Table 19: South Asia Market Value (US$ Million) Analysis 2014 to 2021 and Forecast 2022 to 2029, By Country

Table 20: South Asia Market Value (US$ Million) Analysis 2014 to 2021 and Forecast 2022 to 2029, By Product Type

Table 21: South Asia Market Value (US$ Million) Analysis 2014 to 2021 and Forecast 2022 to 2029, By Application

Table 22: South Asia Market Value (US$ Million) Analysis 2014 to 2021 and Forecast 2022 to 2029, By End User

Table 23: East Asia Market Value (US$ Million) Analysis 2014 to 2021 and Forecast 2022 to 2029, By Country

Table 24: East Asia Market Value (US$ Million) Analysis 2014 to 2021 and Forecast 2022 to 2029, By Product Type

Table 25: East Asia Market Value (US$ Million) Analysis 2014 to 2021 and Forecast 2022 to 2029, By Application

Table 26: East Asia Market Value (US$ Million) Analysis 2014 to 2021 and Forecast 2022 to 2029, By End User

Table 27: Oceania Market Value (US$ Million) Analysis 2014 to 2021 and Forecast 2022 to 2029, By Country

Table 28: Oceania Market Value (US$ Million) Analysis 2014 to 2021 and Forecast 2022 to 2029, By Product Type

Table 29: Oceania Market Value (US$ Million) Analysis 2014 to 2021 and Forecast 2022 to 2029, By Application

Table 30: Oceania Market Value (US$ Million) Analysis 2014 to 2021 and Forecast 2022 to 2029, By End User

Table 31: MEA Market Value (US$ Million) Analysis 2014 to 2021 and Forecast 2022 to 2029, By Country

Table 32: MEA Market Value (US$ Million) Analysis 2014 to 2021 and Forecast 2022 to 2029, By Product Type

Table 33: MEA Market Value (US$ Million) Analysis 2014 to 2021 and Forecast 2022 to 2029, By Application

Table 34: MEA Market Value (US$ Million) Analysis 2014 to 2021 and Forecast 2022 to 2029, By End User

Table 35: India Market Value (US$ Million) Analysis 2014 to 2021 and Forecast 2022 to 2029, By Product Type

Table 36: India Market Value (US$ Million) Analysis 2014 to 2021 and Forecast 2022 to 2029, By Application

Table 37: India Market Value (US$ Million) Analysis 2014 to 2021 and Forecast 2022 to 2029, By End User

Table 38: Brazil Market Value (US$ Million) Analysis 2014 to 2021 and Forecast 2022 to 2029, By Product Type

Table 39: Brazil Market Value (US$ Million) Analysis 2014 to 2021 and Forecast 2022 to 2029, By Application

Table 40: Brazil Market Value (US$ Million) Analysis 2014 to 2021 and Forecast 2022 to 2029, By End User

Table 41: China Market Value (US$ Million) Analysis 2014 to 2021 and Forecast 2022 to 2029, By Product Type

Table 42: China Market Value (US$ Million) Analysis 2014 to 2021 and Forecast 2022 to 2029, By Application

Table 43: China Market Value (US$ Million) Analysis 2014 to 2021 and Forecast 2022 to 2029, By End User

Sabyasachi Ghosh

Principal Consultant

Talk to Analyst

Find your sweet spots for generating winning opportunities in this market.

List of Charts

Figure 01: Global Market Value Analysis, 2014 to 2021

Figure 02: Global Market Forecast & Y-o-Y Growth, 2022 to 2029

Figure 03: Global Market Absolute $ Opportunity (US$ Million) Analysis, 2022 to 2029

Figure 04: Global Market Y-o-Y Growth (%) Analysis, 2022 to 2029

Figure 05: Global Market Value Share (%) Analysis 2022 & 2029, By Product Type

Figure 06: Global Market Y-o-Y Growth (%) Analysis 2022 to 2029, By Product Type

Figure 07: Global Market Attractiveness Analysis 2022 to 2029, By Product Type

Figure 08: Global Market Value Share (%) Analysis 2022 & 2029, By Application

Figure 09: Global Market Y-o-Y Growth (%) Analysis 2022 to 2029, By Application

Figure 10: Global Market Attractiveness Analysis 2022 to 2029, By Application

Figure 11: Global Market Value Share (%) Analysis 2022 & 2029, By End User

Figure 12: Global Market Y-o-Y Growth (%) Analysis 2022 to 2029, By End User

Figure 13: Global Market Attractiveness Analysis 2022 to 2029, By End User

Figure 14: Global Market Value Share (%) Analysis 2022 & 2029, By Region

Figure 15: Global Market Y-o-Y Growth (%) Analysis 2022 to 2029, By Region

Figure 16: Global Market Attractiveness Analysis 2022 to 2029, By Region

Figure 17: North America Market Value Analysis, 2014 to 2021

Figure 18: North America Market Forecast & Y-o-Y Growth, 2022 to 2029

Figure 19: North America Market Attractiveness Analysis, By Product Type

Figure 20: North America Market Attractiveness Analysis, By Application

Figure 21: North America Market Attractiveness Analysis, By End User

Figure 22: North America Market Attractiveness Analysis, By Country

Figure 23: Latin America Market Value Analysis, 2014 to 2021

Figure 24: Latin America Market Forecast & Y-o-Y Growth, 2022 to 2029

Figure 25: Latin America Market Attractiveness Analysis, By Product Type

Figure 26: Latin America Market Attractiveness Analysis, By Application

Figure 27: Latin America Market Attractiveness Analysis, By End User

Figure 28: Latin America Market Attractiveness Analysis, By Country

Figure 29: Europe Market Value Analysis, 2014 to 2021

Figure 30: Europe Market Forecast & Y-o-Y growth, 2022 to 2029

Figure 31: Europe Market Attractiveness Analysis, By Product Type

Figure 32: Europe Market Attractiveness Analysis, By Application

Figure 33: Europe Market Attractiveness Analysis, By End User

Figure 34: Europe Market Attractiveness Analysis, By Country

Figure 35: South Asia Market Value Analysis, 2014 to 2021

Figure 36: South Asia Market Forecast & Y-o-Y Growth, 2022 to 2029

Figure 37: South Asia Market Attractiveness Analysis, By Product Type

Figure 38: South Asia Market Attractiveness Analysis, By Application

Figure 39: South Asia Market Attractiveness Analysis, By End User

Figure 40: South Asia Market Attractiveness Analysis, By Country

Figure 41: East Asia Market Value Analysis, 2014 to 2021

Figure 42: East Asia Market Forecast & Y-o-Y Growth, 2022 to 2029

Figure 43: East Asia Market Attractiveness Analysis, By Product Type

Figure 44: East Asia Market Attractiveness Analysis, By Application

Figure 45: East Asia Market Attractiveness Analysis, By End User

Figure 46: East Asia Market Attractiveness Analysis, By Country

Figure 47: Oceania Market Value Analysis, 2014 to 2021

Figure 48: Oceania Market Forecast & Y-o-Y growth, 2022 to 2029

Figure 49: Oceania Market Attractiveness Analysis, By Product Type

Figure 50: Oceania Market Attractiveness Analysis, By Application

Figure 51: Oceania Market Attractiveness Analysis, By End User

Figure 52: Oceania Market Attractiveness Analysis, By Country

Figure 53: MEA Market Value Analysis, 2014 to 2021

Figure 54: MEA Market Forecast & Y-o-Y growth, 2022 to 2029

Figure 55: MEA Market Attractiveness Analysis, By Product Type

Figure 56: MEA Market Attractiveness Analysis, By Application

Figure 57: MEA Market Attractiveness Analysis, By End User

Figure 58: MEA Market Attractiveness Analysis, By Country

Figure 59: Global Market Value Proportion Analysis, By Emerging Countries, 2018

Figure 60: Market, Global Vs. Country Growth Y-o-Y (%) Comparison, 2022 to 2029

Figure 61: India Market Value Analysis, 2014 to 2021

Figure 62: India Market Forecast & Y-o-Y growth, 2022 to 2029

Figure 63: India Market Attractiveness Analysis, By Product Type

Figure 64: India Market Attractiveness Analysis, By Application

Figure 65: India Market Attractiveness Analysis, By End User

Figure 66: Brazil Market Value Analysis, 2014 to 2021

Figure 67: Brazil Market Forecast & Y-o-Y growth, 2022 to 2029

Figure 68: Brazil Market Attractiveness Analysis, By Product Type

Figure 69: Brazil Market Attractiveness Analysis, By Application

Figure 70: Brazil Market Attractiveness Analysis, By End User

Figure 71: China Market Value Analysis, 2014 to 2021

Figure 72: China Market Forecast & Y-o-Y growth, 2022 to 2029

Figure 73: China Market Attractiveness Analysis, By Product Type

Figure 74: China Market Attractiveness Analysis, By Application

Figure 75: China Market Attractiveness Analysis, By End User